loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of All Manufacturers & Suppliers for 204785 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

    Client Virtual Booth
    Menu

    XSPIRE

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE (1)

    filter

    01 XSPIRE PHARMA (1)

    filter

    01 CAPSULE;ORAL (1)

    filter

    01 320.5MG;30MG;16MG (1)

    filter

    01 USA (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag U.S.A
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Acetaminophen; Caffeine; Dihydrocodeine Bitartrate

      PDF Supplier PDF
      URL Supplier Web Content
      CAPSULE;ORAL
      320.5MG;30MG;16MG
      TREZIX
      USA
      204785
      2014-11-26
      RX
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Looking for CTD TGA MCC DOSSIER APPLICATION 204785

      Looking for CTD TGA MCC DOSSIER APPLICATION 204785 1

      19

      XSPIRE, based in U.S.A, is a pharmaceutical company.

      One of their notable products is ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE, with a corresponding application number 204785 and regulatory information .

      proudly manufactured in the

      approval since 2014-11-26

      XSPIRE's TREZIX CAPSULE;ORAL, medication with 320.5MG;30MG;16MG of ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE.

      Post Enquiry
      POST ENQUIRY